Literature DB >> 15596770

Neoplastic meningitis-related encephalopathy: prognostic significance.

Marc C Chamberlain1, Denice Tsao-Wei, Susan Groshen.   

Abstract

Two cohorts of 20 patients diagnosed with neoplastic meningitis (NM) with or without encephalopathy were matched with respect to age, sex, primary tumor, and performance status. Median survival was 10 weeks (range 6 to 20 weeks) in the cohort with NM-related encephalopathy compared to 24 weeks (range 8 to 40 weeks) in the cohort without NM-related encephalopathy (p < 0.001). NM-related encephalopathy is a clinical variable that predicts for poor survival in patients with NM.

Entities:  

Mesh：

Year:  2004        PMID： 15596770     DOI： 10.1212/01.wnl.0000145599.06491.71

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  9 in total

1.  Leptomeningeal metastasis of pulmonary large-cell neuroendocrine carcinoma: A case report and review of the literature.

Authors:  Guozi Yang; Zhenyu Pan; Ning Ma; Limei Qu; Tingting Yuan; Xiaochuan Pang; Xu Yang; Lihua Dong; Shixin Liu
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

2.  A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.

Authors:  E Le Rhun; S Taillibert; F Zairi; N Kotecki; P Devos; A Mailliez; V Servent; L Vanlemmens; P Vennin; T Boulanger; M C Baranzelli; C André; G Marliot; J L Cazin; F Dubois; R Assaker; J Bonneterre; M C Chamberlain
Journal:  J Neurooncol       Date:  2013-03-01       Impact factor: 4.130

3.  Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.

Authors:  Laura Harstad; Kenneth R Hess; Morris D Groves
Journal:  Neuro Oncol       Date:  2008-08-14       Impact factor: 12.300

4.  A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

Authors:  Morris D Groves; Michael J Glantz; Marc C Chamberlain; Karen E Baumgartner; Charles A Conrad; Sigmund Hsu; Jeffrey S Wefel; Mark R Gilbert; Sandra Ictech; Kathy U Hunter; Arthur D Forman; Vinay K Puduvalli; Howard Colman; Kenneth R Hess; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2008-03-03       Impact factor: 12.300

5.  Acute confusion in patients with systemic cancer.

Authors:  V Doriath; M Paesmans; G Catteau; J Hildebrand
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.506

6.  Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.

Authors:  Zhenyu Pan; Guozi Yang; Hua He; Gang Zhao; Tingting Yuan; Yu Li; Weiyan Shi; Pengxiang Gao; Lihua Dong; Yunqian Li
Journal:  Int J Cancer       Date:  2016-06-30       Impact factor: 7.396

7.  Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Surg Neurol Int       Date:  2013-05-02

8.  Intrathecal pemetrexed combined with involved-field radiotherapy as a first-line intra-CSF therapy for leptomeningeal metastases from solid tumors: a phase I/II study.

Authors:  Zhenyu Pan; Guozi Yang; Hua He; Jiuwei Cui; Wei Li; Tingting Yuan; Kunzhi Chen; Tongchao Jiang; Pengxiang Gao; Yanan Sun; Xiaofeng Cong; Zhi Li; Yongxiang Wang; Xiaochuan Pang; Yuanyuan Song; Gang Zhao
Journal:  Ther Adv Med Oncol       Date:  2020-07-17       Impact factor: 8.168

9.  Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine.

Authors:  Garry Ceccon; Michael Wollring; Anna Brunn; Martina Deckert; Dirk Waldschmidt; Gereon R Fink; Norbert Galldiks
Journal:  Case Rep Oncol       Date:  2020-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.